QIAGEN dividend
MyStockButler's October 2026 analysis: QIAGEN paid $0.35 per share in July 2026 after paying nothing from 2021 through 2024. Free cash flow supports continuation, but rising net debt and suspended guidance keep the payout uncertain.
How much does QIAGEN pay its shareholders?
The dividend is treated as a new policy, not an established cycle-tested record. QIAGEN paid $0.35 per share in July 2026 after paying nothing from 2021 through 2024. The base case rounds a modest increase to $0.39 per share, the bear case assumes a pause, and the bull case increases the payout by about $0.05 annually. Free cash flow supports continuation, but rising net debt and suspended guidance keep the payout uncertain.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| − Dividends paid, per share | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 |
| − Share buybacks, per share | 1.28 | 1.30 | 0.00 | 0.00 | 0.43 |
| = FCF not paid out, per share | 0.54 | 0.95 | 1.34 | 2.55 | 1.50 |
How much would QIAGEN's dividend pay you?
€10,000 invested in QIAGEN at its 0.7% dividend yield (our report of October 23, 2026) pays €70.00 in the first year, before tax. If its dividend stays flat and the dividends are reinvested, year 10 pays €74.54, with €722.47 received in all.
Before tax. Past dividend growth is not a promise. Information only, not investment advice.
Is QIAGEN’s dividend covered by its cash?
The cash pattern shows competing priorities. QIAGEN paid shareholders while continuing to acquire businesses, so acquisitions were not funded only from one year’s free cash flow. In 2023 it retained all its free cash flow and spent on acquisitions, including BLIRT, a Polish supplier of enzymes and proteins used in laboratory reagents. The disclosed movements show what QIAGEN spent, but not whether each purchase generated enough cash afterward.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Free cash flow | 453,277 | 506,377 | 309,745 | 586,040 | 449,097 |
| − Dividends paid | 54,243 | 0 | 0 | 0 | 0 |
| − Share buybacks | 280,086 | 292,099 | 0 | 0 | 99,987 |
| = Free cash flow not paid out | 118,948 | 214,278 | 309,745 | 586,040 | 349,110 |
| Paid out, % of free cash flow | 73.8% | 57.7% | 0.0% | 0.0% | 22.3% |
What this means. The company's own net debt is identical to our net debt, while the “paid out, percentage of real free cash flow” is higher because it measures payouts after subtracting payments made with shares.
What could change QIAGEN’s dividend?
Operating evidence would then decide the standalone path. Stronger repeat orders from QIAcuity consumables, wider QIAstat-Dx use and automation-driven kit demand through 2027–2029 would support the bull case. Continued weak research and screening demand, or low use of installed instruments, would weaken earnings, cash generation and the multiple.
What is QIAGEN’s dividend yield today?
At €44.935, buying every share would cost €9,278.85 million. A buyer taking control also inherits borrowings and receives the company’s cash, producing an enterprise value of €10.04 billion. Enterprise value therefore measures the operating business more completely than market value alone because lenders are paid before shareholders.
| Today (Oct 22, 2026) | |
|---|---|
| Share price | 44.935 |
| Free cash flow yield (calculated) | 4.4% |
| Real free cash flow yield (calculated) | 3.9% |
| Dividend yield (calculated) | 0.7% |